Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
Clovis Oncology reports 2018 executive compensation
By ExecPay News
Published: April 26, 2019
Clovis Oncology reported fiscal year 2018 executive compensation information on April 26, 2019.
In 2018, five executives at Clovis Oncology received on average a compensation package of $2.6M, a 26% decrease compared to previous year.
Average pay of disclosed executives at Clovis Oncology
Patrick J. Mahaffy, Chief Executive Officer, received $6.3M in total, which decreased by 28% compared to 2017. 83% of Mahaffy's compensation, or $5.2M, was in option awards. Mahaffy also received $390K in bonus, $689K in salary, as well as $15K in other compensation.
For fiscal year 2018, the median employee pay was $349,809 at Clovis Oncology. Therefore, the ratio of Patrick J. Mahaffy's pay to the median employee pay was 18 to one.
Lindsey Rolfe, Chief Medical Officer, received a compensation package of $1.8M, which decreased by 25% compared to previous year. 35% of the compensation package, or $643K, was in stock awards.
Gillian C. Ivers-Read, EVP and Chief Regulatory Officer, earned $1.8M in 2018, a 26% decrease compared to previous year.
C. Dale Hooks, Former Senior VP and Chief Commercial Officer, received $1.6M in 2018, which decreases by 20% compared to 2017.
Daniel W. Muehl, Senior VP of Finance, Principal Accounting Officer, and Principal Financial Officer, earned $1.5M in 2018, a 20% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2019.